{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:33:05Z","timestamp":1790271185166,"version":"4.1.0"},"reference-count":46,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Key Research and Development Project of Ningxia (Talent Introduction Project)","award":["2022BSB03063"],"award-info":[{"award-number":["2022BSB03063"]}]},{"name":"Key Research and Development Project of Ningxia (Talent Introduction Project)","award":["2022AAC03078"],"award-info":[{"award-number":["2022AAC03078"]}]},{"name":"Natural Science Foundation of Ningxia","award":["2022BSB03063"],"award-info":[{"award-number":["2022BSB03063"]}]},{"name":"Natural Science Foundation of Ningxia","award":["2022AAC03078"],"award-info":[{"award-number":["2022AAC03078"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>The research purpose was to investigate the effects and the underlying molecular mechanisms of bovine bone gelatin peptides (BGP) on myocardial hypertrophy in spontaneously hypertensive rats (SHR). BGP relieved myocardial hypertrophy and fibrosis in SHR rats in a dose-dependent manner by reducing the left ventricular mass index, myocardial cell diameter, myocardial fibrosis area, and levels of myocardial hypertrophy markers (atrial natriuretic and brain natriuretic peptide). Label-free quantitative proteomics analysis showed that long-term administration of BGP changed the left ventricle proteomes of SHR. The 37 differentially expressed proteins in the high-dose BGP group participated in multiple signaling pathways associated with cardiac hypertrophy and fibrosis indicating that BGP could play a cardioprotective effect on SHR rats by targeting multiple signaling pathways. Further validation experiments showed that a high dose of BGP inhibited the expression of phosphoinositide 3-kinase (Pi3k), phosphorylated protein kinase B (p-Akt), and transforming growth factor-beta 1 (TGF-\u03b21) in the myocardial tissue of SHR rats. Together, BGP could be an effective candidate for functional nutritional supplements to inhibit myocardial hypertrophy and fibrosis by negatively regulating the TGF-\u03b21 and Pi3k\/Akt signaling pathways.<\/jats:p>","DOI":"10.3390\/nu15245021","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T06:01:07Z","timestamp":1701842467000},"page":"5021","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effects of Long-Term Administration of Bovine Bone Gelatin Peptides on Myocardial Hypertrophy in Spontaneously Hypertensive Rats"],"prefix":"10.3390","volume":"15","author":[{"given":"Songmin","family":"Cao","sequence":"first","affiliation":[{"name":"School of Food Science and Engineering, Ningxia University, Yinchuan 750021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Food Science and Engineering, Ningxia University, Yinchuan 750021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujuan","family":"Xing","sequence":"additional","affiliation":[{"name":"Key Lab of Meat Processing and Quality Control, MOE, College of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Lab of Meat Processing and Quality Control, MOE, College of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijcard.2017.03.002","article-title":"Hypertension, left ventricular hypertrophy, and sudden cardiac death","volume":"237","author":"Shenasa","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_2","first-page":"H552","article-title":"Differential cardiac hypertrophy and signaling pathways in pressure versus volume overload","volume":"314","author":"You","year":"2017","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.intimp.2017.05.002","article-title":"Stachydrine ameliorates isoproterenol-induced cardiac hypertrophy and fibrosis by suppressing inflammation and oxidative stress through inhibiting NF-\u03baB and JAK\/STAT signaling pathways in rats","volume":"48","author":"Zhao","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1172\/JCI31044","article-title":"ECM remodeling in hypertensive heart disease","volume":"117","author":"Berk","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"11267","DOI":"10.1038\/ncomms11267","article-title":"The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling","volume":"7","author":"Ji","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ncb1137","article-title":"Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II","volume":"6","author":"Zou","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/1753944716642677","article-title":"Cardiac remodelling and RAS inhibition","volume":"10","author":"Ferrario","year":"2016","journal-title":"Ther. Adv. Cardio. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","article-title":"Physiological and pathological cardiac hypertrophy","volume":"97","author":"Shimizu","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"s9","DOI":"10.1067\/mhj.2000.102902","article-title":"Therapeutic options in minimizing left ventricular hypertrophy","volume":"139","author":"Devereux","year":"2000","journal-title":"Am. Heart J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0140-6736(15)60110-6","article-title":"Effects of long-term use of cardiovascular drugs","volume":"385","author":"Julian","year":"2015","journal-title":"Lancet"},{"key":"ref_12","first-page":"97","article-title":"The physiological activity of bioactive peptides obtained from meat and meat by-products","volume":"97","author":"Xing","year":"2021","journal-title":"Adv. Food Nutr. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1021\/acs.jafc.9b05618","article-title":"Antihypertensive effects in vitro and in vivo of novel angiotensin-converting enzyme inhibitory peptides from bovine bone gelatin hydrolysate","volume":"68","author":"Cao","year":"2020","journal-title":"J. Agr. Food Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1080\/10408398.2018.1436038","article-title":"Exploration of collagen recovered from animal by-products as a precursor of bioactive peptides: Successes and challenges","volume":"59","author":"Fu","year":"2019","journal-title":"Crit. Rev. Food Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.fbp.2020.03.001","article-title":"Structure and physical properties of gelatin from bovine bone collagen influenced by acid pretreatment and pepsin","volume":"121","author":"Cao","year":"2020","journal-title":"Food Bioprod. Process."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pcad.2019.11.009","article-title":"Left ventricular hypertrophy and hypertension","volume":"63","author":"Yildiz","year":"2020","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jprot.2016.12.012","article-title":"Unraveling proteo123me changes of Holstein beef M. semitendinosus and its relationship to meat discoloration during post-mortem storage analyzed by label-free mass spectrometry","volume":"154","author":"Yu","year":"2017","journal-title":"J. Proteomics"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"9877","DOI":"10.1021\/acs.jafc.2c02982","article-title":"Bovine bone gelatin-derived peptides: Food processing characteristics and evaluation of anti-hypertensive and antihyperlipidemic activities","volume":"70","author":"Cao","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1021\/acs.jproteome.8b00276","article-title":"Proteomics of the rat myocardium during development of Type 2 diabetes mellitus reveals progressive alterations in major metabolic pathways","volume":"17","author":"Edhager","year":"2018","journal-title":"J. Proteome Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11906-013-0354-3","article-title":"Aldosterone mediates cardiac fibrosis in the setting of hypertension","volume":"15","author":"Azibani","year":"2013","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The pathogenesis of cardiac fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/CIRCRESAHA.116.305381","article-title":"Getting to the heart of the matter","volume":"116","author":"Leask","year":"2015","journal-title":"Circ. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.biopha.2017.06.002","article-title":"Fusaric acid (FA) protects heart failure induced by isoproterenol (ISP) in mice through fibrosis prevention via TGF-\u03b21\/SMADs and PI3K\/AKT signaling pathways","volume":"93","author":"Li","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.cell.2013.04.015","article-title":"Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy","volume":"153","author":"Loffredo","year":"2013","journal-title":"Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0008-6363(02)00341-3","article-title":"Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart","volume":"55","author":"Yamamoto","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1016\/j.jacc.2013.04.004","article-title":"B-type natriuretic peptide and survival in hypertrophic cardiomyopathy","volume":"61","author":"Geske","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jep.2013.10.017","article-title":"Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4\/NF-\u03baB signaling pathway in isoproterenol-induced myocardial hypertrophy","volume":"150","author":"Yang","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1056\/NEJMra072139","article-title":"Cardiac plasticity","volume":"358","author":"Hill","year":"2008","journal-title":"New Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0735-1097(01)01433-4","article-title":"Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy","volume":"38","author":"Rapacciuolo","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41467-017-02795-4","article-title":"AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation","volume":"9","author":"Gelinas","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1074\/jbc.275.7.4693","article-title":"Gbetagamma-dependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy","volume":"275","author":"Naga","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev.physiol.63.1.391","article-title":"Cytoplasmic signaling pathways that regulate cardiac hypertrophy","volume":"63","author":"Molkentin","year":"2001","journal-title":"Annu. Rev. Physiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/415206a","article-title":"Seven-transmembrane-spanning receptors and heart function","volume":"415","author":"Rockman","year":"2002","journal-title":"Nature"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI10079","article-title":"Meeting Koch\u2019s postulates for calcium signaling in cardiac hypertrophy","volume":"105","author":"Chien","year":"2000","journal-title":"J. Clin. Investig."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0092-8674(00)80043-4","article-title":"Stress pathways and heart failure","volume":"98","author":"Chien","year":"1999","journal-title":"Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","article-title":"Hypertrophy of the heart","volume":"109","author":"Frey","year":"2004","journal-title":"Circulation"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1089\/ten.tea.2014.0412","article-title":"PI3K phosphorylation is linked to improved electrical excitability in an in vitro engineered heart tissue disease model system","volume":"21","author":"Kana","year":"2015","journal-title":"Tissue Eng. Part A"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1172\/JCI24682","article-title":"Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure","volume":"115","author":"Shiojima","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1172\/JCI23073","article-title":"PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia\/reperfusion injury","volume":"115","author":"Nagoshi","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jtcvs.2006.07.042","article-title":"Roles of cyclooxygenase-2 and phosphorylated Akt (Thr308) in cardiac hypertrophy regression mediated by left-ventricular unloading","volume":"133","author":"Wohlschlaeger","year":"2007","journal-title":"J. Thorac. Cardiov. Sur."},{"key":"ref_41","first-page":"355","article-title":"Rosuvastatin inhibits TGF-beta1 expression and alleviates myocardial fibrosis in diabetic rats","volume":"68","author":"Ma","year":"2013","journal-title":"Die Pharm."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/CIRCRESAHA.110.217737","article-title":"Potential therapeutic targets for cardiac fibrosis TGF beta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation","volume":"106","author":"Leask","year":"2010","journal-title":"Circ. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI0214190","article-title":"TGF-\u03b21 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II","volume":"109","author":"Schultz","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/HYPERTENSIONAHA.109.136531","article-title":"Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-\u03b2-dependent and -independent smad pathways: The role of Smad3","volume":"54","author":"Yang","year":"2009","journal-title":"Hypertension"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2008.12.049","article-title":"Angiotensin II increases collagen I expression via transforming growth factor-beta1 and extracellular signal-regulated kinase in cardiac fibroblasts","volume":"606","author":"Gao","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0895-7061(00)01257-7","article-title":"Left ventricular hypertrophy and angiotensin II antagonists","volume":"14","year":"2001","journal-title":"Am. J. Hypertens."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/15\/24\/5021\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:34:06Z","timestamp":1760132046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/15\/24\/5021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,6]]},"references-count":46,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["nu15245021"],"URL":"https:\/\/doi.org\/10.3390\/nu15245021","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,6]]}}}